Urine Specific Proteins and Alpha-1 Antitrypsin Concentrations to Assess the Severity of Lupus Nephritis

Hani Susianti, Wisnu Barlianto, Dian Sukma Hanggara, Kusworini Handono, Purwanto Adipireno, Lisyani Suromo


Background. Current biomarkers for evaluating disease activity or severity in lupus nephritis (LN) are considered to be unsatisfactory. Pathological changes in glomerular basement membrane and selectivity of electrical discharge are causing specific patterns of urine proteins excretion. Together with alpha-1 antitrypsin (AAT), they are expected to become new biomarkers to assess LN activity.

Method. Seventy-one urine samples were collected from healthy controls and LN patients. Patterns of urine specific proteins were determined using column chromatography and SDS-PAGE tests, LN activity was calculated using SLEDAI-renal domain score, and AAT concentrations was measured by ELISA.

Result. The majority of proteins in the control group have molecular weights of >66 kDa (88%) and 21- to 25-kDa proteins were observed only in the case group. The p values for differences in urine AAT concentration between active LN and healthy controls, inactive LN and healthy controls, and active LN and inactive LN were 0.004, 0.046, and 0.054, respectively, whereas those for urine AAT/creatinine ratio were 0.489, 0.019, and 0.915, respectively.

Conclusion: There were differences in the patterns of the molecular weight of proteins and urine AAT concentrations between case group and control group. However, no such differences were identified between active and inactive LN. 


Lupus nephritis activity; Patterns of urine specific proteins; Urine alpha-1 antitrypsin

Full Text:



Almaani, S., Meara, A., & Rovin, B. H. (2016). Update on lupus nephritis. Clin J Am Soc Nephrol. Doi: 10.2215/CJN.05780616.

Baraldo, S., Turato, G., Lunardi, F., Bazzan, E., Schiavon, M., Ferrarotti, I. … Rea, F. (2015). Immune activation of alpha1-antitrypsin-deficiency emphysema. Beyond the protease-antiprotease paradigm. Am J Respir Crit Care Med,191(4): 402-409.

Ganji, S. M., Jazii, F. R., & Sahebghadam-Lotfi, A. (2012). Structural Features, Biological Functions of the Alpha-1 Antitrypsin and Contribution to Esophageal Cancer. In: Li, X (Ed.). Squamous Cell Carcinoma. (pp. 281-291). Shanghai: InTech.

Janciauskiene, S. M., Bals, R., Koczulla, R., Vogelmeier, C., Köhnlein, T., & Welte, T. (2011). The discovery of α1-antitrypsin and its role in health and disease. Respir Med, 105(8): 1129-1139.

Hahn, B.H. (2008). Systemic lupus erythematosus. In A. S. Fauci, D. L. Kasper, D. L. Longo, E. Braunwald, S. L. Hauser, J. L. Jameson, & J. Loscalzo (Eds.), Harrison’s PRINCIPLE OF INTERNAL MEDICINE (17th ed.) (pp. 2075-2083). New York, NY: Mc-Graw Hill.

Handono, K. (2010). Peran polimorfisme gen IFN-γ pada fenotip histologi nefritis lupus. Indonesian Journal of Clinical Pathology and Medical Laboratory, 17: 38-43.

Hsieh, Y. P., Wen, Y. K., & Chen, M. L. (2012). The value of early renal biopsy in systemic lupus erythematosus patients presenting with renal involvement. Clin Nephrol, 77(1), 18-24.

Kim, K., Brown, E. E., Choi, C. B., Alarcón-Riquelme, M. E., BIOLUPUS, Kelly, J. A., … Bae, S. C. (2012). Variation in the ICAM1-ICAM4-ICAM5 locus is associated with systemic lupus erythematosus susceptibility in multiple ancestries. Ann Rheum Dis, 71(11), 1809-1814.

Longo, D. L., Kasper, D. L., Jameson, J. L., Fauci, A. S, Hauser, S. L., & Loscalzo, J. (Eds.). (2012). Harrison’s PRINCIPLES OF INTERNAL MEDICINE Vol. 1 (18th ed.). New York, NY: Mc-Graw Hill.

Moreno, J. A., Gomez, A. O., Navarro, A. R., Louedec, L., Ho-Tin-Noe, B., Caligiuri, G., … Meilhac, O. (2014). High-density lipoproteins potentiate α1-antitrypsin therapy in elastase-induced pulmonary emphysema. Am J Respir Cell Mol Biol, 51(4): 536-549.

Ortiz, G., Salica, J. P., Chuluyan, E. H., & Gallo, J. E. (2014). Diabetic retinopathy: could the alpha-1 antitrypsin be a therapeutic option?. Biol Res, 47:58. Doi:10.1186/0717-6287-47-58.

Quimby, K. R., Flower, C., Hambleton, I. R., Landis, R. C., & hennis, A. J. M. (2013). Comparison of the systemic lupus erythematosus activity questionnaire and the systemic lupus erythematosus activity index in a black Barbadian population. International Journal of Rheumatology, 2013, article ID 875369. doi:10.1155/2013/875369.

Santucci, L., Candiano, G., Bruschi, M., Bodria, M., Murtas, C., Petretto, A., & Ghiggeri, G. M. (2013). Urinary Proteome in A Snapshot:Normal Urine and Glomerulonephritis. J Nephrol, 26(4): 610-616.

Sarcina, C., Tinelli, C., Ferrario, F., Pani, A., De Silvestri, A., & Scaini, P. (2016). Changes in proteinuria and side effects of corticosteroids alone or in combination with azathioprine at different stages of IgA nephropathy. Clin J Am Soc Nephrol, 11(6): 973-981.

Saxena, V., Lienesch, D. W., Zhou, M., Bommireddy, R., Azhar, M., & Doetschman, T. (2008). Dual roles of immunoregulatory cytokine TGF-ß in the pathogenesis of autoimmunity-mediated organ damage. J Immunol, 180(3): 1903-1912.

Susanti, H., Wijaya, J. W., Rastini, A., Handono, K., Gunawan, A. & Kalim, H. (2015). Urinary Neutrophil Gelatinase-Associated Lipocalin to Monitor Lupus Nephritis Disease Activity. Biomark Insights, 10, 81-87.

Suzuki, M., Wiers, K. M., Klein-Gitelman, M. S., Haines, K. A., Olson, J., Onel, K. B., … Brunner, H. I. (2008). Neutrophil gelatinase associated lipocalin as a biomarker of disease activity in pediatric lupus nephritis. Pediatr Nephrol, 23(3), 403-412.

Varghese, S. A., Powell, T. B., Budisavljevic, M. N., Oates, J. C., Raymond, J. R., Almeida, J. S., & Arthur, J. M. (2007). Urine biomarkers predict the cause of glomerular disease. J Am Soc Nephrol, 18(3), 913–922.

Wu, J., Chen, Y. D., & Gu, W. (2010). Urinary proteomics as a novel tool for biomarker discovery in kidney diseases. J Zheijang Univ Sci B, 11(4), 227-237.

Zager, R. A., Johnson A. C. M., & Frostad, K. B. (2014). Rapid Renal Alpha-1 Antitrypsin Gene Induction in Experimental and Clinical Acute Kidney Injury. PLoS ONE, 9(5):1-5.

Zhang, X., Jin, M., Wu, H., Nadasdy , T., Nadasdy, G., Harris, N., … Rovain, B. H. (2008). Biomarkers of lupus nephritis determined by serial urine proteomics. Kidney Int, 74(6), 799-807.

DOI: https://doi.org/10.21776/ub.rjls.2017.004.01.6


  • There are currently no refbacks.

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.